Venture Investments

We are a life science venture capital investor, delivering knowledge, network, and capital to companies.

About

Novo Holdings Venture Investments is one of the largest and most active life science venture investors globally. Primarily investing in companies that develop innovative drugs and novel

technologies, we provide capital, knowledge and a network to companies in the biotechnology and medical technology sectors, spanning early-stage, translatable science through commercial stage products.

The Venture Investments team employs multiple strategies within the life sciences industry including investing in both private equity and publicly traded equities.  On the private side, Novo Holdings typically leads or co-leads its investments and takes an active ownership role with board participation. On the public side, Novo Holdings participates in company financings and trades in the open market. With teams based in Copenhagen, London, Singapore, Boston and San Francisco, Novo Holdings is positioned in the world’s leading life science hubs and can engage closely with companies and partners globally. Novo Holdings ’ evergreen structure enables the Venture Investments team to take a long-term view to advance science and medicine for the benefit of society.

Venture Investments key figures

Currency
DKK

17

bn

Portfolio value at year-end 2025

53

Portfolio companies

DKK

5

bn

Capital deployed during the year 2025

Our Venture Investments Portfolio

Search

Meet our team

With professionals based out of Copenhagen, San Francisco, Boston and London and an international network of commercial and scientific specialists, our team is geared to invest in the major life science hubs.